Impact News +++ Clover Bio′s COVID-19 vaccine candidates in combination with GSK or Dynavax′s adjuvants show... (SeekingAlpha) +++ DYNAVAX Aktie +3,13%

MIRATI Aktie

 >MIRATI Aktienkurs 
190.88 EUR    (Tradegate)
Ask: 192.75 EUR / 32 Stück
Bid: 189.00 EUR / 32 Stück
Tagesumsatz: 0 Stück
Realtime Kurs von 8 bis 22 Uhr!
>MIRATI Performance
1 Woche: -0,3%
1 Monat: -0,8%
3 Monate: +60,2%
6 Monate: +111,2%
1 Jahr: +101,9%
laufendes Jahr: +64,8%
>MIRATI Aktie
Name:  MIRATI THERAPEUTICS DL-01
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US60468T1051 / A1W1XV
Symbol/ Ticker:  26M (Frankfurt) / MRTX (NASDAQ)
Kürzel:  FRA:26M, 26M.F, 26M:GR, NASDAQ:MRTX
Index:  -
Webseite:  https://www.mirati.com/
Marktkapitalisierung:  9510 Mio. EUR
Umsatz:  10.23 Mio. EUR
EBITDA:  -282.31 Mio. EUR
Gewinn je Aktie:  -6.456 EUR
Schulden:  0.46 Mio. EUR
Liquide Mittel:  489.81 Mio. EUR
Umsatz-/ Gewinnwachstum:  1,056.30% / -
KGV/ KGV lG:  - / -
KUV/ KBV/ PEG:  780.6 / 20.38 / -
Gewinnm./ Eigenkapitalr.:  - / -66.82%
Dividende je Aktie:  -
Dividendenrendite/ -schätzung:  - / -
Insiderhandel:  -
Suchwörter:  MIRATI
Letzte Datenerhebung:  01.12.20
>MIRATI Eigentümer
Aktien: 49.37 Mio. St.
f.h. Aktien: 33.67 Mio. St.
Insider Eigner: 1.86%
Instit. Eigner: 97.19%
Leerverk. Aktien: 8.96%
>MIRATI Peer Group

 
23.11.20 - 22:33
Mirati Therapeutics To Participate In The 2020 Evercore ISI HealthCONx Conference (PR Newswire)
 
SAN DIEGO , Nov. 23, 2020 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced they will participate in a fireside chat at the 2020......
06.11.20 - 20:21
Barnes & Noble Education and MobileIron See Activist Action (MarketWatch)
 
Activists submit filings to the SEC on MobileIron, Turning Point Brands, Mirati Therapeutics, Barnes & Noble Education, and Virtusa...
05.11.20 - 22:36
Mirati Therapeutics To Participate In The 29th Annual Credit Suisse Virtual Healthcare Conference (PR Newswire)
 
SAN DIEGO , Nov. 5, 2020 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced they will participate in a fireside chat at the 29th......
05.11.20 - 02:22
Mirati (MRTX) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
 
Mirati (MRTX) delivered earnings and revenue surprises of 3.92% and 1580.00%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?...
04.11.20 - 23:52
Mirati Therapeutics EPS beats by $0.07 (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
04.11.20 - 22:18
Mirati Therapeutics Reports Third Quarter 2020 Financial Results And Recent Business Highlights (PR Newswire)
 
SAN DIEGO , Nov. 4, 2020 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today reported financial results for the third quarter ended September......
04.11.20 - 20:02
Insiderhandel: Insider verkauft Aktien von Mirati Therapeutics im Wert von 80.800.000 $ (Insiderkauf)
 
Boxer Capital, LLC - Zehn-Prozent-Eigentümer - Tag der Transaktion: 2020-10-30...
30.10.20 - 22:12
Mirati Therapeutics Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters€ Option To Purchase Additional Shares (PR Newswire)
 
Um den gesamten Artikel unter barchart.com zu lesen, klicken Sie bitte auf die Überschrift...
30.10.20 - 14:46
Why Mirati Therapeutics (MRTX) Might Surprise This Earnings Season (Zacks)
 
Mirati Therapeutics (MRTX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season....
28.10.20 - 04:55
Mirati Therapeutics prices equity offering at $202 (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
28.10.20 - 01:09
Mirati Therapeutics Announces Pricing Of Public Offering Of Common Stock (PR Newswire)
 
SAN DIEGO , Oct. 27, 2020 /PRNewswire/ -- Mirati Therapeutics, Inc. (Nasdaq: MRTX) today announced the pricing of an underwritten public offering of 4,335,397 shares of its common stock at a price......
27.10.20 - 13:01
Better Buy: Amgen vs. Mirati Therapeutics (Fool)
 
Which one of these biotech stocks has a better chance to provide market-beating gains?...
26.10.20 - 21:55
Mirati Therapeutics launches equity offering of $700M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
26.10.20 - 21:54
Mirati Therapeutics Announces Proposed Public Offering of Common Stock (PR Newswire)
 
SAN DIEGO , Oct. 26, 2020 /PRNewswire/ -- Mirati Therapeutics, Inc. (Nasdaq: MRTX) today announced that it intends to offer and sell in an underwritten public offering $700.0 million of shares......
26.10.20 - 18:31
Mirati (MRTX) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
 
Mirati (MRTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations....
26.10.20 - 17:01
Why Mirati′s Stock Is Trading Higher Today (Benzinga)
 
Mirati Therapeutics (NASDAQ: MRTX) shares are trading higher on Monday following positive preliminary data for MRTX849 for patients with advanced non-small cell lung cancer. read more...
>Zitat des Tages: Um den Menschen für die Erbsünde zu strafen, hat Gott ihm erlaubt, sich aus seiner Eigenliebe einen Götzen zu schaffen, der ihn nun zeitlebens bei allen seinen Taten quält. - François VI. Duc de La Rochefoucauld
Partner:    >Tradegate Börse | >TraderFox Handelssignale | >Heibel-Ticker Börsenbrief | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf Twitter | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!